|
|
|
This is the preliminary program for the 2008 Joint Statistical
Meetings in Denver, Colorado.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2008 Program page |
= Applied Session,
= Theme Session,
= Presenter|
|
||
| 282 | Tue, 8/5/08, 12:30 PM - 1:50 PM | HY-Capitol Ballroom 4 |
| Biopharmaceutical Section Roundtables with Lunch (fee event) - Roundtables - with Lunch | ||
|
Biopharmaceutical Section |
||
| Organizer(s): Matilde Sanchez, Arena Pharmaceuticals | ||
| TL11: |
Statistical Analysis and Practical Issues of Missing Data in Clinical Pharmacology (Phase I) Crossover Studies —  Fang Liu, Merck Research Laboratories; Pat Larson, Merck Research Laboratories
|
|
| TL12: |
Statistical Challenges and Opportunities in Oncology Clinical Trials — Yi He, sanofi-aventis; Zhenming Shun, sanofi-aventis; Martin Roessner, sanofi-aventis
|
|
| TL13: |
Statistical Issues in Thorough QT Studies — Jennifer E. Hamer-Maansson, AstraZeneca Pharmaceuticals
|
|
| TL14: |
Successful Partnership Between CRO and Sponsor Statisticians — Nfii Ndikintum, Paragon Biomedical, Inc.
|
|
| TL15: |
Stratified Trials with Binary Endpoints: Saving $$$ with More Efficient Analyses — Devan V. Mehrotra, Merck Research Laboratories
|
|
| TL16: |
Use of Biomarkers and Models in Exploratory Clinical Development — Alan Y. Chiang, Eli Lilly and Company
|
|
|
JSM 2008
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |